PharmaLex has entered into a joint venture with life sciences and healthcare strategic consultancy Vintura.
The partnership will provide benefits for both organisations – Vintura will be able to access the expertise offered by PharmaLex’s global reach in 31 offices across 17 countries, and PharmaLex is set to build on its service portfolio offering to clients with Vintura’s specialisms.
The two organisations will continue to operate under their respective, well-established brands.
“We are very excited to be joining forces with the PharmaLex Group,” said Gérard Klop, partner at Vintura.
“PharmaLex has a very strong heritage in the life sciences sector and we see clear synergies between our two organisations. In addition, the international footprint of PharmaLex supports our international growth objectives,” he added.
PharmaLex is a specialist service provider for the pharmaceutical industry, offering services for development consulting, regulatory affairs, quality management & compliance and pharmacovigilance.
Vintura is a strategy and organisation consultancy with speciality in healthcare and life sciences, and has offices based in Amsterdam, the Netherlands and Munich, Germany.